ELEKTA'S ELECTION COMMITTEE APPOINTED PRESS RELEASE Stockholm, Sweden, October 17, 2007 In accordance with the decision at the Annual General Meeting on September 25, 2007, Elekta's Board Chairman Akbar Seddigh has October contacted the company's largest shareholders to form an Election Committee. Subsequently, the shareholders agreeing to participate in the work of the Election Committee each nominated a representative. The shareholders and representatives comprising the Nomination Committee are: Anders Algotsson AFA Insurance Jan-Erik Erenius AMF Pension Laurent Leksell representing his private and companies' holdings Ole E. Dahl Orkla ASA Åsa Nisell Swedbank Robur Funds Combined, per September 30, 2007, these shareholders represented over 45 percent of the votes in Elekta AB. The Election Committee held its first meeting on October 16, and appointed Laurent Leksell as chairman. The Election Committee will form a proposal to the Board of Directors and prepare other matters prior to the Annual General Meeting on September 2008. The Committee's assignment remains effective until a new Election Committee is appointed. Shareholders wishing to submit proposals to Elekta's Nomination Committee 2008 can contact the Nomination Committee by e-mail at valberedningen@elekta.com or by letter to: Elekta AB, Attention: Valberedningen, Box 7593, 103 93 Stockholm. ****** For further information, please contact: Peter Ejemyr, Group VP Corporate Communications Tel: +46 733 611 000 (mobile), e-mail: peter.ejemyr@elekta.com About Elekta Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight serious disease. Elekta provides advanced clinical solutions, comprehensive management and information systems as well as services for improved cancer care and management of brain disorders. Elekta's systems and solutions are used in over 4,500 hospitals around the world. Clinical and information management solutions include, among others, Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR and efficient management of clinical and patient data. With over 2,000 employees globally, the corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information about Elekta can be found at www.elekta.com.
ELEKTA'S ELECTION COMMITTEE APPOINTED
| Source: Elekta AB